INS and exocrine pancreatic carcinoma: This is in line with previous observations supporting the notion that, lowering HMGA1 protein abundance in pancreatic carcinoma cells that naturally overexpress HMGA1 and are highly responsive to insulin and IGFs, may impair the G1 phase progression by downregulating the protein expression of cyclin D1 (51).